This website uses cookies to enhance the user experience.
GENINOVA AS

GENINOVA AS983 568 823

Research
Limited company
Storhamargata 44 2317 HAMAR, Norge

GENINOVA AS

Home - Norsvin
Norsvin SA er et avlsselskap eid og styrt av norske svineprodusenter. I tillegg til arbeidet med utvikling, produksjon og salg av svinegenetikk nasjonalt og internasjonalt, arbeider vi for at norske svineprodusenter skal ha best mulige rammebetingelser.

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
23 years
since Aug 4, 2001
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
100
1 share class
Total number of shareholders
2
companies

Financials

Annual total result 2023
-3,021
NOK
Total equity 2023
773,624
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
Board Member-

Others

NameRoleShares
P
PRICEWATERHOUSECOOPERS AS
Accountant-
Last update: Jul 2, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
A
AQUAGEN AS
Ordinary shares
50
50 %
N
NORSVIN SA
Ordinary shares
50
50 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
0
0
0
Annual Total Result
-3,021
-9,363
-24,144
Total assets
773,624
776,645
786,008
Total liabilities
0
0
0
Total equity
773,624
776,645
786,008

P&L

Year202320222021
Total operating income
0
0
0
Total operating costs
29,751
19,624
24,702
Operating result
-29,751
-19,624
-24,702
Financial income/costs
26,730
10,261
558
Profit before tax
-3,021
-9,363
-24,144
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-3,021
-9,363
-24,144

Balance overview

Year202320222021
Total fixed assets
0
0
0
Total current assets
773,624
776,645
786,008
Total assets
773,624
776,645
786,008
Short term debt
0
0
0
Long term debt
0
0
0
Total liabilities
0
0
0
Contributed capital
200,000
200,000
200,000
Retained earnings
573,624
576,645
586,008
Total equity
773,624
776,645
786,008
Total equity and liabilities
773,624
776,645
786,008

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology